Portfolio update 23/3 2021
As stated in yesterdays portfolio update I sold off part of my position in Enzymatica. Today I have bought back the majority of these shares below 10 sek. Analyst house Erik Penser has lowered the target price to 16-17 SEK which is still quite appealing compared to the current share price of around 10 SEK ( at time




